Seelaus Asset Management LLC Invitae Corp Transaction History

Seelaus Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$11.71 - $30.29 $321,907 - $832,672	-27,490 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$7.64 - $27.5 $1,910 - $6,875	-250 Reduced 0.9%	27,490 $376,000
Q2 2019 Jul 31, 2019	BUY	$17.37 - $26.27 $11,290 - $17,075	650 Added 2.4%	27,740 $652,000
Q4 2018 Feb 08, 2019	SELL	$9.26 - $16.38 $2,315 - $4,094	-250 Reduced 0.91%	27,090 $300,000
Q2 2018 Jul 18, 2018	SELL	$4.87 - $8.42 $10,714 - $18,524	-2,200 Reduced 7.45%	27,340 $201,000
Q1 2018 May 07, 2018	BUY	$4.69 - $10.05 $70,350 - $150,750	15,000 Added 103.16%	29,540 $139,000
Q4 2017 Feb 14, 2018	BUY	$7.86 - $9.99 $114,284 - $145,254	14,540	14,540 $132,000

2.08M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Seelaus Asset Management LLC with notifications on news.